1. Adkins, D. E., Clark, S. L., Åberg, K., Hettema, J. M., Bukszár, J., McClay, J. L., et al. (2012). Genome-wide pharmacogenomic study of citalopram-induced side effects in STAR*D. Translational Psychiatry,2, e129.
2. American Psychiatric Association. (2010). American Psychiatric association practice guideline for the treatment of patients with major depressive disorder (3rd ed.). https://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidleines/guidelines/mdd.pdf.
3. Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in Psychology,3, 77–101.
4. Byng, R., Bury, C., & Weaver, L. (2007). Patients’ experiences of consultations for depression and predictors of adherence to antidepressants. Primary Care and Community Psychiatry,12(3/4), 109–115.
5. Cipriani, A., Furukawa, T., Salanti, G., Chaimani, A., Atkinson, L., Ogawa, Y., et al. (2018). Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: A systematic review and network meta-analysis. The Lancet,391(10128), 1357–1366.